Kidney Research and Clinical Practice

Pleotropic effects of hypoxia-inducible factor-prolyl hydroxylase domain inhibitors: are they clinically relevant?: Yu-Hsiang Chou, Szu-Yu Pan, Shuei-Liong Lin; Received June 6, 2022 Accepted June 30, 2022 Published online November 21, 2022; [Epub ahead of print]; Full text PubReader ePub Crossref - TDM PDF

Healthy aging and chronic kidney disease: Reshma Aziz Merchant, Anantharaman Vathsala; Kidney Res Clin Pract. 2022;41(6):644-656. Published online October 25, 2022; DOI: https://doi.org/10.23876/j.krcp.22.112; Full text PubReader ePub Crossref - TDM PDF

Diabetic kidney disease treatment: new perspectives: Li-Li Tong, Sharon G. Adler; Kidney Res Clin Pract. 2022;41(Suppl 2):S63-S73. Published online September 30, 2022; DOI: https://doi.org/10.23876/j.krcp.21.288; Full text PubReader ePub Crossref - TDM PDF

Serum cystatin C to creatinine ratio is associated with sarcopenia in non-dialysis-dependent chronic kidney disease: Jung Nam An, Jwa-Kyung Kim, Hyung-Seok Lee, Sung Gyun Kim, Hyung Jik Kim, Young Rim Song; Kidney Res Clin Pract. 2022;41(5):580-590. Published online June 24, 2022; DOI: https://doi.org/10.23876/j.krcp.21.214
Cited By 1; Full text PubReader ePub Crossref - TDM PDF Supplementary Material

Ambulatory blood pressure trajectories and blood pressure variability in kidney transplant recipients: a comparative study against chronic kidney disease patients: Maria Korogiannou, Marieta Theodorakopoulou, Pantelis Sarafidis et al.; Kidney Res Clin Pract. 2022;41(4):482-491. Published online June 22, 2022; DOI: https://doi.org/10.23876/j.krcp.21.250
Cited By 1; Full text PubReader ePub Crossref - TDM PDF Supplementary Material

Management of autosomal dominant polycystic kidney disease in the era of disease-modifying treatment options: Yeshwanter Radhakrishnan, Parikshit Duriseti, Fouad T. Chebib; Kidney Res Clin Pract. 2022;41(4):422-431. Published online March 29, 2022; DOI: https://doi.org/10.23876/j.krcp.21.309
Cited By 1; Full text PubReader ePub Crossref - TDM PDF

Nutrition and quality of life in chronic kidney disease patients: a practical approach for salt restriction: Kunitoshi Iseki; Kidney Res Clin Pract. 2022;41(6):657-669. Published online January 21, 2022; DOI: https://doi.org/10.23876/j.krcp.21.203
Cited By 1; Full text PubReader ePub Crossref - TDM PDF

Global Kidney Health Atlas: a spotlight on the Asia-Pacific sector: Joyita Bharati, Vivekanand Jha; Kidney Res Clin Pract. 2022;41(1):22-30. Published online January 13, 2022; DOI: https://doi.org/10.23876/j.krcp.21.236
Cited By 2; Full text PubReader ePub Crossref - TDM PDF

Prostaglandin E2 receptors as therapeutic targets in renal fibrosis: Henricus A.M. Mutsaers, Rikke Nørregaard; Kidney Res Clin Pract. 2022;41(1):4-13. Published online January 13, 2022; DOI: https://doi.org/10.23876/j.krcp.21.222
Cited By 2; Full text PubReader ePub Crossref - TDM PDF

Association between serum osteoprotegerin level and renal prognosis in nondialysis patients with chronic kidney disease in the Korean Cohort Study for Outcomes in Patients with Chronic Kidney Disease (the KNOW-CKD Study): Tae Ryom Oh, Chana Myeong, Su Hyun Song et al.; Kidney Res Clin Pract. 2022;41(2):200-208. Published online December 29, 2021; DOI: https://doi.org/10.23876/j.krcp.21.173
Cited By 1; Full text PubReader ePub Crossref - TDM PDF

Metformin use and cardiovascular outcomes in patients with diabetes and chronic kidney disease: a nationwide cohort study: Min-Ho Kim, Hyung Jung Oh, Soon Hyo Kwon et al.; Kidney Res Clin Pract. 2021;40(4):660-672. Published online November 29, 2021; DOI: https://doi.org/10.23876/j.krcp.20.222
Cited By 1; Full text PubReader ePub Crossref - TDM PDF Supplementary Material

Angiotensin receptor-neprilysin inhibitor in patients with heart failure and chronic kidney disease: In-Jeong Cho, Seok-Min Kang; Kidney Res Clin Pract. 2021;40(4):555-565. Published online November 22, 2021; DOI: https://doi.org/10.23876/j.krcp.21.900
Cited By 1; Full text PubReader ePub Crossref - TDM PDF

Association between blood pressure and the risk of chronic kidney disease in treatment-naïve hypertensive patients: Haekyung Lee, Soon Hyo Kwon, Jin Seok Jeon, Hyunjin Noh, Dong Cheol Han, Hyoungnae Kim; Kidney Res Clin Pract. 2022;41(1):31-42. Published online November 17, 2021; DOI: https://doi.org/10.23876/j.krcp.21.099
Cited By 1; Full text PubReader ePub Crossref - TDM PDF Supplementary Material

The roles of sodium and volume overload on hypertension in chronic kidney disease: Jinho Shin, Chang Hwa Lee; Kidney Res Clin Pract. 2021;40(4):542-554. Published online November 17, 2021; DOI: https://doi.org/10.23876/j.krcp.21.800
Cited By 1; Full text PubReader ePub Crossref - TDM PDF

Pericoronary fat attenuation index in computed tomography angiography is associated with mortality in end-stage renal disease: Nam-Jun Cho, Bo Da Nam, Samel Park et al.; Kidney Res Clin Pract. 2022;41(1):66-76. Published online November 16, 2021; DOI: https://doi.org/10.23876/j.krcp.21.090
Cited By 3; Full text PubReader ePub Crossref - TDM PDF Supplementary Material

4,587	Korean Society of Nephrology 2022 Recommendations on controversial issues in diagnosis and management of hyponatremia
6,043	Management of autosomal dominant polycystic kidney disease in the era of disease-modifying treatment options
4,579	Renal side effects of COVID-19 vaccines in patients with immunoglobulin A nephropathy
9,207	Pediatric acute kidney injury: new advances in the last decade
6,317	Diagnosis of renal transplant rejection: Banff classification and beyond

Cited By 39	Mitochondrial dysfunction in kidney injury, inflammation, and disease: potential therapeutic approaches
Cited By 24	Diagnosis of renal transplant rejection: Banff classification and beyond
Cited By 24	Trends in epidemiologic characteristics of end-stage renal disease from 2019 Korean Renal Data System (KORDS)
Cited By 22	Reduced risk for chronic kidney disease after recovery from metabolic syndrome: A nationwide population-based study
Cited By 21	The KNOW-CKD Study: What we have learned about chronic kidney diseases

Search